The UK Medicines and Healthcare products Regulatory Agency is inviting feedback on an updated guideline on data integrity issues, which has been substantially revised in scope to cover all aspects of pharmaceutical development and good laboratory practice studies regulated by the agency.
Also, the updated document addresses some gaps in the previous version of the guideline and clarifies expectations where inspections showed...








